BYW6 GER Week ended 31 Jul 2026

Weekly Investor Report

BayWa Aktiengesellschaft · Industrials · Conglomerates

Open interactive chart View report data
Latest close 2.73 EUR
1.9% latest week
Weekly setup

Mixed setup

The weekly trend is not active. Price is -4.5% below the Trend Line and sits at 9.4% of its 52-week range. The latest completed week returned 1.9%, after a 7.3% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. The latest news-sentiment score is 50/100.

Setup score 36 out of 100
Latest Close 2.73 EUR 31 Jul 2026
1W Return 1.9% latest completed week
4W Return 7.3% short-term follow-through
12W Return 0.9% quarterly tape
Trend Breadth 13.5% 7 of 52 weeks active
Volume Ratio 1.6x vs 13-week average
What is working
  • Activity pressure is positive on the latest completed week.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • Next-week expectancy is negative at 38.28% based on similar historical setup states.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.9% Latest completed week; four-week move 7.3%. Indicator stack 7/94 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Next-Week Expectancy Negative 38.28% Historical one-week expectancy contributes to the evidence score when direction is confirmed. News sentiment 50/100 1 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -4.5% below the Trend Line and sits at 9.4% of its 52-week range. The latest completed week returned 1.9%, after a 7.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.0512-week average 0.03

12-week confirmation

Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 7.3% over four weeks, 0.9% over 12 weeks, and -50.2% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.9%
4W7.3%
12W0.9%
26W-20.0%
52W-50.2%
Active trend streak0 weeks
Active weeks in one year7
Trend breadth13.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.08Latest activity-pressure read.
Pressure change312.4%Four-week change in activity pressure.
Leadership-24.29Latest relative-leadership reading.
RS change29.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 30 Jun 2025 Field coverage 70% Model confidence 37%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength66/100Blend of value, momentum, and quality. Underlying universe rank 35; rank 1 is best.
Value56/100Relative valuation strength. Underlying universe rank 45; rank 1 is best.
Quality54/100Profitability and accounting quality. Underlying universe rank 47; rank 1 is best.
Momentum56/100Medium-term price momentum. Underlying universe rank 45; rank 1 is best.
Growth59/100Revenue and earnings growth. Underlying universe rank 42; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
12.6%
Gross profit retained from each unit of revenue.
Operating margin
-4.0%
Operating profit retained from revenue.
Free-cash-flow margin
1.6%
Free cash flow generated from revenue.
Return on invested capital
-14.3%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-11.3%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-
Net share repurchases relative to market value.
Shareholder yield
-
Dividend yield plus net buyback yield.
Net debt / EBITDA
-37.0x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment50/100

Weighted news tone is neutral across 1 relevant articles.

0 positive · 1 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-65.9%Distance below the 52-week high.
13-week volatility5.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2615 weeks finished lower.
Best week+13.9%Week of 3 Jul.
Worst week-9.5%Week of 13 Mar.
Latest week+1.9%Week of 31 Jul.

Shape of recent returns

Strong gains2
Modest gains9
Flat weeks0
Modest losses10
Sharp losses5
Recent vol5.1%13-week weekly-return volatility.
Base vol10.2%52-week weekly-return volatility.
Up/down split20/32Count of positive and negative weeks in the 52-week window.
Average skew7.2% / -5.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape30/100

Trend, activity pressure, participation, and risk combine to a 30/100 tape read.

 Indicator analysis18/100

Latest 12-week confirmation: trend 0/12, activity pressure 5/12, relative leadership 0/12.

Activity pressure 0.05; No reversal markers Next-Week ExpectancyNegative 38.28%

Next-week expectancy is negative with a 38.28% historical one-week setup read.

Adds short-term historical context without overriding trend, activity, or relative leadership. Factors57/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 50; Small Cap Core rank 57 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment50/100

Weighted news tone is neutral across 1 relevant articles.

BayWa AG: Target Price Consensus and Analysts Recommendations | BYW6 | DE0005194062 Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20262.73 EUR1.9%2.85 EUR8.11 EUR1.08-24.29154.6KOff
24 Jul 20262.67 EUR3.3%2.86 EUR8.23 EUR1.01-25.41106.6KOff
17 Jul 20262.59 EUR1.6%2.86 EUR8.35 EUR0.71-28.3950.8KOff
10 Jul 20262.55 EUR0.4%2.85 EUR8.48 EUR0.47-31.23112.1KOff
3 Jul 20262.54 EUR13.9%2.85 EUR8.60 EUR0.26-34.28233.5KOff
26 Jun 20262.23 EUR-6.9%2.85 EUR8.72 EUR-0.03-40.5960.4KOff
19 Jun 20262.40 EUR-7.5%2.86 EUR8.84 EUR-0.06-37.9414.5KOff
12 Jun 20262.59 EUR-1.3%2.86 EUR8.96 EUR-0.14-32.8213.8KOff
5 Jun 20262.62 EUR0.4%2.86 EUR9.09 EUR-0.25-33.1155.2KOff
29 May 20262.62 EUR0.2%2.94 EUR9.21 EUR-0.30-34.99104.7KOff
22 May 20262.61 EUR-1.1%3.03 EUR9.33 EUR-0.37-35.38100.5KOff
15 May 20262.64 EUR-2.2%3.08 EUR9.45 EUR-0.46-32.8182.3KOff
8 May 20262.70 EUR-3.6%3.14 EUR9.57 EUR-0.48-33.07206.1KOff
1 May 20262.80 EUR1.6%3.19 EUR9.68 EUR-0.53-31.16130.6KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.